PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will
PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Chairman and Chief Executive Officer Al Altomari will prese

Agile Therapeutics Inc Shares Close in on 52-Week Low - Market Mover

11:29am, Wednesday, 29'th Dec 2021 Kwhen Finance
Agile Therapeutics Inc (AGRX) shares closed today at 0.5% above its 52 week low of $0.50, giving the company a market cap of $61M. The stock is currently down 82.5% year-to-date, down 82.9% over the past 12 months, and down 91.8% over the past five years. This week, the Dow Jones Industrial Average rose 3.9%, and the S&P 500 rose 4.9%. Trading Activity Trading volume this week was 4.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 13495.7% The company's stock price performance over the past 12 months lags the peer average by -24030.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Analysts expect Agile Therapeutics, Inc. (NASDAQ:AGRX) to report $1.76 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Agile Therapeutics earnings, with estimates ranging from $1.70 million to $1.81 million. Agile Therapeutics reported sales of $750,000.00 during the same quarter last year, which indicates a positive year []
Agile Therapeutics, Inc. (NASDAQ:AGRX) with the stream of -8.80% also noticed, India CooTek (Cayman) Inc. (NYSE:CTK) encountered a rapid change of -7.41% in the last hour of Fridays trading session. The post Alarming Stock: Agile Therapeutics, Inc. (NASDAQ:AGRX), CooTek (Cayman) Inc. (NYSE:CTK) appeared first on Stocks Equity .
Agile Therapeutics, Inc. (NASDAQ:AGRX) with the stream of -7.72% also noticed, India Teva Pharmaceutical Industries Limited (NYSE:TEVA) encountered a rapid change of 0.37% in the last hour of Tuesdays trading The post Hair-raising Facts to Know: Agile Therapeutics, Inc. (NASDAQ:AGRX), Teva Pharmaceutical Industries Limited (NYSE:TEVA) appeared first on Stocks Equity .

Agile Therapeutics, Inc. (NASDAQ:AGRX) Shares Sold by State Street Corp

09:08am, Wednesday, 08'th Dec 2021 Dakota Financial News
State Street Corp trimmed its stake in Agile Therapeutics, Inc. (NASDAQ:AGRX) by 73.1% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 290,345 shares of the specialty pharmaceutical companys stock after selling 787,565 shares during the quarter. State Street Corp owned approximately []
Agile Therapeutics, Inc. (AGRX) with the stream of -2.52% also noticed, India Galiano Gold Inc. (GAU) encountered a rapid change of 2.52% in the last hour of trading session. Agile The post Have an attention on: Agile Therapeutics, Inc. (NASDAQ:AGRX), Galiano Gold Inc. (AMEX:GAU) appeared first on Stocks Equity .
Millennium Management LLC bought a new stake in Agile Therapeutics, Inc. (NASDAQ:AGRX) during the 2nd quarter, HoldingsChannel reports. The institutional investor bought 1,504,056 shares of the specialty pharmaceutical companys stock, valued at approximately $2,000,000. A number of other large investors have also recently modified their holdings of AGRX. Goldman Sachs Group Inc. raised its holdings []
Gold Standard Ventures Corp (GSV) with the stream of 3.55% also noticed, India Agile Therapeutics, Inc. (AGRX) encountered a rapid change of -2.52% in the last hour of Fridays trading The post Traders cant brush off this: Gold Standard Ventures Corp (AMEX:GSV), Agile Therapeutics, Inc. (NASDAQ:AGRX) appeared first on Stocks Equity .
A contraceptive is a device or drug that avoids a woman from becoming pregnant. Some contraceptives avoid pregnancy by averting ovulation. A kind of birth control that works the best to prevent pregnancy is the insert and IUDs they''re also

Top Penny Stocks For Your Under $1 List Right Now

09:22am, Wednesday, 01'st Dec 2021
Check these Under $1 penny stocks out for your watchlist The post Top Penny Stocks For Your Under $1 List Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com
Agile Therapeutics Inc. (NASDAQ:AGRX) traded at $0.57 at close of the session on Monday, 11/29/21, made an upward move of 3.52% on its previous days price. Looking at the stock we see that its previous close was $0.55 and the beta (5Y monthly) reads 1.02 with the days price range being $0.54 $0.5773. In Are Investors Keen On Selling Holdings In Agile Therapeutics Inc. (NASDAQ: AGRX)? Read More »
Agile Therapeutics, Inc. (AGRX) with the stream of 3.52% also noticed, India Venus Concept Inc. (VERO) encountered a rapid change of -1.46% in the last hour of Mondays trading session. The post Flashy Stock: Agile Therapeutics, Inc. (NASDAQ:AGRX), Venus Concept Inc. (NASDAQ:VERO) appeared first on Stocks Equity .
Royal Bank of Canada grew its stake in shares of Agile Therapeutics, Inc. (NASDAQ:AGRX) by 6.5% during the second quarter, Holdings Channel reports. The institutional investor owned 994,071 shares of the specialty pharmaceutical companys stock after purchasing an additional 60,835 shares during the quarter. Royal Bank of Canadas holdings in Agile Therapeutics were worth $1,322,000 []
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE